Literature DB >> 15531294

Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice.

Shigeto Hontsu1, Hiroyuki Yoneyama, Satoshi Ueha, Yuya Terashima, Masahiro Kitabatake, Akiko Nakano, Toshihiro Ito, Hiroshi Kimura, Kouji Matsushima.   

Abstract

CD25+CD4+ regulatory T cells (Treg) play pivotal roles in the host response to tumors. However, their exact location in vivo is largely unknown. The forkhead/winged helix transcription factor, Foxp3, is specifically expressed in naturally occurring Treg (nTreg) and programs their development and function. In this study, we produced a rabbit polyclonal antibody (pAb), which can detect mouse Foxp3 protein in situ. Results using this pAb revealed that Foxp3+CD4+ nTreg cells occur in direct contact with CD11c+ dendritic cells (DCs), and Foxp3-CD4+ and CD8+T lymphocytes in the T cell regions of lymphoid tissues from normal and tumor-bearing mice. The numbers of Foxp3+CD4+ nTreg cells are significantly increased in draining, but not nondraining, lymph nodes (LNs) and spleen (SPL) of tumor-bearing mice. Furthermore, a small number of nTreg could be also found at the tumor site. These observations support the notion that the numbers of Foxp3+CD4+ nTreg are increased by tumors and may contribute to the immunosuppression observed in tumor-bearing hosts at secondary lymphoid organs and also possibly at the tumor site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531294     DOI: 10.1016/j.intimp.2004.07.026

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  10 in total

Review 1.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 2.  Special regulatory T-cell review: Suppressors regulated but unsuppressed.

Authors:  Judith A Kapp
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

3.  CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue.

Authors:  Sunil K Chauhan; Daniel R Saban; Thomas H Dohlman; Reza Dana
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

Review 4.  Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

Authors:  V Kumar
Journal:  Purinergic Signal       Date:  2012-12-28       Impact factor: 3.765

5.  Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.

Authors:  Nelson C Di Paolo; Sebastian Tuve; Shaoheng Ni; Karl Erik Hellström; Ingegerd Hellström; André Lieber
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

7.  Single blood transfusion induces the production of donor-specific alloantibodies and regulatory T cells mainly in the spleen.

Authors:  Hisashi Ueta; Yusuke Kitazawa; Yasushi Sawanobori; Takamasa Ueno; Satoshi Ueha; Kouji Matsushima; Kenjiro Matsuno
Journal:  Int Immunol       Date:  2018-03-08       Impact factor: 4.823

8.  Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells.

Authors:  Hisashi Ueta; Xue-Dong Xu; Bin Yu; Yusuke Kitazawa; Enqiao Yu; Yoshiaki Hara; Miwa Morita-Nakagawa; Shu Zhou; Yasushi Sawanobori; Satoshi Ueha; Kazuhito Rokutan; Toshiya Tanaka; Nobuko Tokuda; Kouji Matsushima; Kenjiro Matsuno
Journal:  Int Immunol       Date:  2021-04-22       Impact factor: 4.823

9.  Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.

Authors:  Karthick Raja Muthu Raja; Lucie Rihova; Lenka Zahradova; Maria Klincova; Miroslav Penka; Roman Hajek
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Effect of Apatinib on Serum CD4+CD25+ T cells, NK Cells, and T Cells Subgroup in Malignant Tumor.

Authors:  Hui-Qin Luo; Yi-Fu He; Wen-Ju Chen; Ying Yan; Shu-Sheng Wu; Xiao-Xiu Hu; Li-Hong Ke; Jia-Yu Niu; Hui-Min Li; Hui-Jun Xu
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.